What is the recommended dosing for Pepcid (Famotidine) in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Famotidine (Pepcid) Dosing in Adults

The recommended standard dosage of famotidine (Pepcid) for adults with normal renal function is 20 mg twice daily or 40 mg once daily, with specific dosing adjustments required for patients with renal impairment. 1

Standard Dosing by Indication

Indication Recommended Dosage Duration
Active duodenal ulcer 40 mg once daily OR 20 mg twice daily Up to 8 weeks
Active gastric ulcer 40 mg once daily Up to 8 weeks
Symptomatic non-erosive GERD 20 mg twice daily Up to 6 weeks
Erosive esophagitis 20 mg twice daily OR 40 mg twice daily Up to 12 weeks
Pathological hypersecretory conditions Starting: 20 mg every 6 hours (adjust as needed) Maximum: 160 mg every 6 hours As clinically indicated
Prevention of duodenal ulcer recurrence 20 mg once daily 1 year or as clinically indicated

Dosing in Renal Impairment

Dosage adjustments are essential for patients with moderate to severe renal impairment:

  • Moderate impairment (CrCl 30-60 mL/min):

    • Most indications: 20 mg once daily OR 40 mg every other day
    • Pathological hypersecretory conditions: Avoid use
  • Severe impairment (CrCl <30 mL/min):

    • Most indications: 20 mg every other day
    • Pathological hypersecretory conditions: Avoid use

Special Considerations

NSAID-Associated Ulcers

  • For prevention of NSAID-associated ulcers: 40 mg twice daily has been shown to significantly reduce the incidence of both gastric and duodenal ulcers in patients on long-term NSAID therapy 2
  • For healing of existing NSAID-associated ulcers: 40 mg twice daily achieves healing rates of 89% at 12 weeks even when patients continue NSAID treatment 3

Erosive Esophagitis

  • For erosive/ulcerative reflux esophagitis, 40 mg twice daily is more effective and achieves faster healing than 20 mg twice daily, particularly for more severe cases 4
  • Healing rates at 12 weeks: 76% with 40 mg twice daily vs. 67% with 20 mg twice daily

Stress Ulcer Prophylaxis

  • For stress ulcer prophylaxis in critically ill patients, low-dose famotidine is recommended (≤40 mg daily) 5
  • Discontinue stress ulcer prophylaxis when critical illness resolves or risk factors are no longer present

Administration Considerations

  • Can be taken with or without food
  • For once-daily dosing, administration at bedtime is common
  • For twice-daily dosing, typically given in the morning and evening
  • No dosage adjustment needed for hepatic impairment
  • Avoid unnecessary polypharmacy; famotidine alone is often sufficient for acid suppression 6

Monitoring

  • For patients on long-term therapy, monitor:
    • Renal function
    • Mental status
    • Complete blood count
    • Use lowest effective dose for shortest duration necessary 6

Potential Pitfalls

  1. Renal adjustment errors: Failing to adjust dose in patients with renal impairment can lead to drug accumulation
  2. Unnecessary combination therapy: Adding a second acid-suppressing medication rarely provides additional benefit if famotidine alone adequately controls symptoms 6
  3. Prolonged use without indication: Discontinue therapy when no longer clinically indicated to prevent unnecessary medication exposure

Famotidine has a favorable safety profile compared to other H2 receptor antagonists, with higher potency and fewer clinically significant drug interactions, allowing for effective acid suppression at relatively low doses 6, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.